Prospective randomized controlled trials should investigate the impact of vitamin D supplementation in combination with GLP-1 receptor agonists, with a focus on doseresponse relationships and long-term metabolic outcomes
Cherry is designed to support a wide range of providers from wellness and weight management clinics to bariatric surgeons performing complex procedures
Those who stayed on treatment lost an average of 11.7% of their body weight
From an aesthetic perspective, this matters because: GLP-1 RAs influence body composition, reducing lean mass, which might alter diffusion or uptake of injectables They impact systemic metabolism which may alter the pharmacokinetics or pharmacodynamics of other drugs As more patients on GLP-1 therapy request cosmetic injectables, including botulinum toxin, the potential for interaction becomes clinically relevant
"The important factor is that some weight was not regained, and when you look at the loss from baseline weight, it's about 4% to 5% of the baseline weight that was lost and maintained